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ABSRACT
Failure to comply with drug regimes is prevalent amongst patients with epilepsy and the consequence of this is often an 
increased risk of further seizures and other associated harms including increased health care costs. Contributing factors 
leading to non-compliance of anti-epileptic drugs has not been examined in Pakistan. We investigated the factors influencing 
non-compliance to prescribed antiepileptic drugs (AEDs). A cross-sectional study was employed for a total of 53 epileptic 
patients with non-compliance of  anti-epileptic drugs. The  data-collection tools were a questionnaire and structured interview 
for this study. Results showed that males were more liable to non-compliance of AEDs as compared to females. Medication 
complexity (more than 2 antiepileptic drugs), treatment duration (>6 months) and elderly age (> 55 years) were the major 
reasons of non-compliance. Further implementation of educational programmes for people with epilepsy would help to 
improve levels of compliance thereby reducing the risk of unnecessary seizures.
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Introduction:
Epilepsy is a common and widespread neurological disorder, 
affecting people of all ages and socioeconomic classes 
worldwide.1 Of those diagnosed with epilepsy, the vast majority 
of such patients are advised with antiepileptic drugs (AEDs) 
and approximately 70% may become seizure-free once the 
most effective regime is followed.2 However, approximately 
every third of patients with epilepsy continue to experience 
seizures despite the prescription of appropriate doses of 
AEDs.3 Poor compliance to AEDs may be the most important 
cause of poorly controlled epilepsy. The term “compliance” 
describes the extent to which a patient takes medications, as 
prescribed with respect to dosage and dosing intervals.4 
Non-compliance to treatment is widespread especially for 
chronic disease and is considered to be a significant problem 
faced by medical practice. Failing to comply increases the 
likelihood of hospital admissions, thus there could be a 
potential saving to the health care services if compliance could 
be improved. The term non-compliance lists following aspects 
in its definition: not taking the correct dosage (too much or too 
little), failing to leave the recommended length of time 
between doses, not taking medication for the duration 
specified, taking other drugs not prescribed. Some physicians 
believe that any patient who fails to adhere on one occasion or 
more is non-compliant whereas others feel that only those who 
fail to comply more than occasionally, say at least 25% of the 
time, should be classed as non-compliant.5 Non-compliance 
to AEDs by epileptic patients has been reported to be high and 
studies have demonstrated a higher prevalence of seizures 
(21-45%) in those who did not comply to their AED 
regimens.6,7 In addition, non-compliance to AEDs has been 
reported to increase morbidity and mortality, as well as 
decrease quality of life and productivity.9 Non-compliance was 
also reported to be associated with reduced mental and 
emotional wellbeing, including impaired cognition. Of the 
world’s 50 million people with epilepsy, 85% live in developing 
countries.1 However, few studies on compliance have been 
performed in Asian and developing countries.5 However, none 
of those was conducted in Pakistan in order to determine 
prevalence of non-compliance and factors which lead to 
non-compliance of AEDs in epileptic patients. We therefore 
conducted this study on a sample of adult patients with 
epilepsy to examine major factors associated with 
non-compliance to AEDs.
Materials and Methods
The cross-sectional study was conducted in OPD (Outpatient 
Department) at Services Institute of Medical Sciences and 
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Services Hospital, Lahore, Pakistan. Male and female patients, 
aged 10 to 70 years, who had been diagnosed with epilepsy 
at least one year previously, were included in this 6-month 
study which was originaly conducted in 1st July- 30th 
December 2012. Patients who met the following criteria were 
also invited to participate in this study: (1) therapy 
recommended with at least one AED, irrespective of any 
standard or non-standard treatment; (2) suspected or 
reported non-compliance to AEDs and (3) no change in AEDs 
in the last six months. Patients with 
comorbidities(Diabetes,Ischemic heart disease)  and those 
who were not able to respond to an interview were excluded.
In this study, we included a total of 225 patients who were 
having the primary diagnosis of Epilepsy. This number was 
calculated statistically with help of software after taking 95% 
confidence interval and 5% absolute precision. Out of these 
225, 53 patients were reported to be non-compliance to 
AEDs. A total of 53 patients reported with non-compliance to 
AEDs were included in the present study. The patients were 
arbitrarily divided into three age groups: an adolescent group 
(10-30 years), an adult group (31-55 years), and an older 
group (56-70 years).  The data-collection tools were a 
questionnaire which was completed through structured 
interview. The patient survey comprised questions regarding 
demographics (gender, age, etc.), seizure history (type and 
frequency), current AED treatments, self-reported 
non-compliance to AEDs, and the reasons of non-compliance. 
The questionnaires were completed in the presence of parents 
for children patients (< 15 years of age). For this study, 
compliance was defined as not missing a dose and 
non-compliance as missing a dose or stopping treatment in 
the last month. The socio-economic status of the patients’ 
parents was determined using variables like area of residence 
and monthly income. In this way, the subjects were 
categorized into Low class if they had a monthly income < 15, 
000 PKR; Middle class if monthly income was betwen 
15,000-30,000; and High class if income was > 30,000. 
Participants gave written informed consent after the purpose 
of the study had been explained to them. The ethics 
committee of the hospital approved the study.
Statistical analyses
The descriptive statistical analysis included examinations of 
means, standard deviations, frequencies, ranges, and 
percentages. The statistical packages SPSS (Version 20) and 
MS Excel (MS Office 2010) were used.
 
Results
In total, 53 patients met all study inclusion criteria, and who 
agreed to participate in the study. The patients came from 
different cities and towns of Lahore division. When epileptic 
patients reported with non-compliance were divided into three 
age groups, adult patients (31-55 years) represented the 
largest age group (36% of all patients) followed by old patients 
(34%) and adolecents (30%) (Figure 1). 
Figure 1. Age distribution of epileptic patients reported with 
non-compliance of AEDs.
Of all patients with non-compliance, 33 (62.3%) were males 
and 20 (37.7%) were females. The mean patient age (±SD) 
was 46.9 (±5.3) years (range: 10-70 years) (Figure 2).
Figure 2. Gender distribution of epileptic patients reported 
with non-compliance of AEDs.
Three main factors were identified in this study which led to 
non-compliance of AEDs in all 53 patients. Age factor, 
Tretment duration and medication complexity were the main 
reasons of non-compliance. Of the all the patients, the primary 
reason was medication complexity. A total of 43.4% patients 
did not comply to the AEDs treatment when the physician 
advised more than two AEDs. This was the major reason of 
non-compliance. Treatment duration was the second largest 
reason attributing the patients towards non-compliance. Of all 
the patients, 34% reported that they could not comply 
because of treatment duration. Treatment duration greater 
than 6 months was cut-off period beyond which there was 
significant non-compliance to AEDs. Third reason of 
non-compliance was age factor as it was reported by 22.6% of 
the patients. Figure 1 clearly shows that non-compliance was 
less frequent in younger population as it shows only 29% of 
the patients. Elderly people specifically aged more than 31-55 
years and 55-70 years could not comply to AEDs.
Figure 3. Frequency of factors contributing towards 
non-compliance of AEDs in Epileptic patients
Socio-economic (education status, economic class) and 
psychosocial factors like Beliefs (myths),Motivation, Attitude of 
the patients were strongly correlated with the non-compliance 
AEDs. Economic class of the patients was mae on the basis of 
monthly income, type of profession and area of residence of 
the patients. On this basis, patients were classified into Low 
class (monthly income < 15000), Middle Class (monthly 
income up to 25000) and High class (monthly income > 
25000). Table 1 shows that non-compliance behavior was 
presented mainly by patients belonging to low (35%) and 
middle class (47%). Similarly non-compliance of AEDs was 
greater in patients with lower education as 47% of the patients 
were having only primary education. Another factor was the 
marital status of the patients. Table 1 clearly shows that 
among all the patients of non-compliance, almost 68% were 
single and only 32% were married.
Discussion
This is the one of the first studies which was carried out to 
investigate the related factors of non-compliance to AEDs in 
epilepsy patients in Pakistan. Compliance is difficult to 
measure accurately. For epilepsy, compliance to medication 
has previously been measured by self-reporting, drug blood 
level monitoring, and prescription refill monitoring. Compliance 
measured by self-reporting may be overestimated but is 
considered to be the simplest and least expensive method. In 
this study, major reasons of non-compliance were measured 
by self-reporting. In our study, 23% of patients were 
non-compliant to AEDs. This percentage was smaller than that 
reported in other countries: Arab countries (64%), the United 
States (29-58%), and the United Kingdom (59%).5,9,10In 
our study, elderly patients aged more than 55 years had the 
highest rates of non-compliance. This may be due to the fact 
that elderly patients have more difficulty in following 
instructions due to cognitive impairment or other physical 
difficulties, such as problems in swallowing tablets, opening 
drug containers, handling small tablets, distinguishing colours 
or identifying markings on drugs.11 The duration of treatment 
period was also a factor that affected non-compliance. In a 
study of epilepsy patients, omission of dose was reported to be 
more frequent with a longer duration of seizure medication 
use.7 The long treatment duration might compromise patients’ 
beliefs about medication effectiveness. In our study, the one of 
three factors that affected compliance was the duration of 
treatment period. There were many factors that influenced 
patients’ perception and beliefs with regards to 
non-compliance because of longer duration of treatment. 
Patients’ knowledge about their disease and treatment is not 
always adequate and they may lack an understanding of the 
role of therapy, be fearful of dependency on long-term 
medication, lack knowledge about the disease and 
consequences of non-compliance, and may assume that the 
need for medication is intermittent and thus stop taking the 
drug in order to see whether medication is still required.12,13
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For these reasons, patient education is very important in order 
to enhance compliance. A poor patient-prescriber relationship 
is another strong factor which affects patient compliance; 
good relationship may enhance compliance. In order to build 
a healthy relationship, physicians should not only question 
patients about seizure frequency and current medication use, 
but also specifically probe them about compliance. They 
should give patients a detailed explanation about the disease, 
treatment regimens, the true side effects, and the importance 
of compliance, and spend more time with the patients.13
Conclusion
Medication compliance remains an important issue in epilepsy 
treatment especially in developing countries. The 
non-compliance of epilepsy patients is common in Pakistan as 
well. Medication complexity (more than 2 antiepileptic drugs), 
treatment duration (>6 months) and elderly age (> 55 years) 
were major reasons of non-compliance. Targeted 
management programs and communication strategies are 
necessary to improve compliance to antiepileptic drug 
treatment for patients with epilepsy and avoid the clinical 
consequences of poor compliance.
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psychosocial factors like Beliefs (myths),Motivation, Attitude of 
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AEDs. Economic class of the patients was mae on the basis of 
monthly income, type of profession and area of residence of 
the patients. On this basis, patients were classified into Low 
class (monthly income < 15000), Middle Class (monthly 
income up to 25000) and High class (monthly income > 
25000). Table 1 shows that non-compliance behavior was 
presented mainly by patients belonging to low (35%) and 
middle class (47%). Similarly non-compliance of AEDs was 
greater in patients with lower education as 47% of the patients 
were having only primary education. Another factor was the 
marital status of the patients. Table 1 clearly shows that 
among all the patients of non-compliance, almost 68% were 
single and only 32% were married.
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investigate the related factors of non-compliance to AEDs in 
epilepsy patients in Pakistan. Compliance is difficult to 
measure accurately. For epilepsy, compliance to medication 
has previously been measured by self-reporting, drug blood 
level monitoring, and prescription refill monitoring. Compliance 
measured by self-reporting may be overestimated but is 
considered to be the simplest and least expensive method. In 
this study, major reasons of non-compliance were measured 
by self-reporting. In our study, 23% of patients were 
non-compliant to AEDs. This percentage was smaller than that 
reported in other countries: Arab countries (64%), the United 
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our study, elderly patients aged more than 55 years had the 
highest rates of non-compliance. This may be due to the fact 
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instructions due to cognitive impairment or other physical 
difficulties, such as problems in swallowing tablets, opening 
drug containers, handling small tablets, distinguishing colours 
or identifying markings on drugs.11 The duration of treatment 
period was also a factor that affected non-compliance. In a 
study of epilepsy patients, omission of dose was reported to be 
more frequent with a longer duration of seizure medication 
use.7 The long treatment duration might compromise patients’ 
beliefs about medication effectiveness. In our study, the one of 
three factors that affected compliance was the duration of 
treatment period. There were many factors that influenced 
patients’ perception and beliefs with regards to 
non-compliance because of longer duration of treatment. 
Patients’ knowledge about their disease and treatment is not 
always adequate and they may lack an understanding of the 
role of therapy, be fearful of dependency on long-term 
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consequences of non-compliance, and may assume that the 
need for medication is intermittent and thus stop taking the 
drug in order to see whether medication is still required.12,13
Economic Class 
(%)  
Marital Status 
(%)  
Psyco-
social 
factor 
(%) 
 Educational level (%)  Forgetfulness (%) 
Low Middle High  Single Married  Yes No  Illetrate Elementary Matric Intermediate  Yes No 
35 47 18  67.9 32.1  68 32  15.1 47.2 20.8 17  49.2 50.8 
 
50
34.0
22.6
Medication complexity
(> 2 AEDs)
Treatment duration>6
months
Age factor
0
10
20
30
40
%
 o
f a
ll 
pa
tie
nt
s
43.4
Factors of Non-compliance
Table 1. Socio-economic and individual factors attributing to non-compliance AEDs in Epileptic patients.
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and 20 (37.7%) were females. The mean patient age (±SD) 
was 46.9 (±5.3) years (range: 10-70 years) (Figure 2).
Figure 2. Gender distribution of epileptic patients reported 
with non-compliance of AEDs.
Three main factors were identified in this study which led to 
non-compliance of AEDs in all 53 patients. Age factor, 
Tretment duration and medication complexity were the main 
reasons of non-compliance. Of the all the patients, the primary 
reason was medication complexity. A total of 43.4% patients 
did not comply to the AEDs treatment when the physician 
advised more than two AEDs. This was the major reason of 
non-compliance. Treatment duration was the second largest 
reason attributing the patients towards non-compliance. Of all 
the patients, 34% reported that they could not comply 
because of treatment duration. Treatment duration greater 
than 6 months was cut-off period beyond which there was 
significant non-compliance to AEDs. Third reason of 
non-compliance was age factor as it was reported by 22.6% of 
the patients. Figure 1 clearly shows that non-compliance was 
less frequent in younger population as it shows only 29% of 
the patients. Elderly people specifically aged more than 31-55 
years and 55-70 years could not comply to AEDs.
Figure 3. Frequency of factors contributing towards 
non-compliance of AEDs in Epileptic patients
Socio-economic (education status, economic class) and 
psychosocial factors like Beliefs (myths),Motivation, Attitude of 
the patients were strongly correlated with the non-compliance 
AEDs. Economic class of the patients was mae on the basis of 
monthly income, type of profession and area of residence of 
the patients. On this basis, patients were classified into Low 
class (monthly income < 15000), Middle Class (monthly 
income up to 25000) and High class (monthly income > 
25000). Table 1 shows that non-compliance behavior was 
presented mainly by patients belonging to low (35%) and 
middle class (47%). Similarly non-compliance of AEDs was 
greater in patients with lower education as 47% of the patients 
were having only primary education. Another factor was the 
marital status of the patients. Table 1 clearly shows that 
among all the patients of non-compliance, almost 68% were 
single and only 32% were married.
Discussion
This is the one of the first studies which was carried out to 
investigate the related factors of non-compliance to AEDs in 
epilepsy patients in Pakistan. Compliance is difficult to 
measure accurately. For epilepsy, compliance to medication 
has previously been measured by self-reporting, drug blood 
level monitoring, and prescription refill monitoring. Compliance 
measured by self-reporting may be overestimated but is 
considered to be the simplest and least expensive method. In 
this study, major reasons of non-compliance were measured 
by self-reporting. In our study, 23% of patients were 
non-compliant to AEDs. This percentage was smaller than that 
reported in other countries: Arab countries (64%), the United 
States (29-58%), and the United Kingdom (59%).5,9,10In 
our study, elderly patients aged more than 55 years had the 
highest rates of non-compliance. This may be due to the fact 
that elderly patients have more difficulty in following 
instructions due to cognitive impairment or other physical 
difficulties, such as problems in swallowing tablets, opening 
drug containers, handling small tablets, distinguishing colours 
or identifying markings on drugs.11 The duration of treatment 
period was also a factor that affected non-compliance. In a 
study of epilepsy patients, omission of dose was reported to be 
more frequent with a longer duration of seizure medication 
use.7 The long treatment duration might compromise patients’ 
beliefs about medication effectiveness. In our study, the one of 
three factors that affected compliance was the duration of 
treatment period. There were many factors that influenced 
patients’ perception and beliefs with regards to 
non-compliance because of longer duration of treatment. 
Patients’ knowledge about their disease and treatment is not 
always adequate and they may lack an understanding of the 
role of therapy, be fearful of dependency on long-term 
medication, lack knowledge about the disease and 
consequences of non-compliance, and may assume that the 
need for medication is intermittent and thus stop taking the 
drug in order to see whether medication is still required.12,13
For these reasons, patient education is very important in order 
to enhance compliance. A poor patient-prescriber relationship 
is another strong factor which affects patient compliance; 
good relationship may enhance compliance. In order to build 
a healthy relationship, physicians should not only question 
patients about seizure frequency and current medication use, 
but also specifically probe them about compliance. They 
should give patients a detailed explanation about the disease, 
treatment regimens, the true side effects, and the importance 
of compliance, and spend more time with the patients.13
Conclusion
Medication compliance remains an important issue in epilepsy 
treatment especially in developing countries. The 
non-compliance of epilepsy patients is common in Pakistan as 
well. Medication complexity (more than 2 antiepileptic drugs), 
treatment duration (>6 months) and elderly age (> 55 years) 
were major reasons of non-compliance. Targeted 
management programs and communication strategies are 
necessary to improve compliance to antiepileptic drug 
treatment for patients with epilepsy and avoid the clinical 
consequences of poor compliance.
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